News

9 - 12 of 217 news items
A project to help improve patient care designed by clinicians from Royal Brompton and Harefield hospitals (RB&HH), in collaboration with colleagues from across King’s Health Partners (KHP), has won in two categories at this year’s ‘Health Tech Digital Awards’ for New Health Tech Innovation of the Year and Best Innovation Project of the Year. The platform allows clinicians to monitor the rate surgical wounds heal after discharge, as well as look for the first signs of possible infections, while saving the patient time by not having to travel into hospital. Read more
To celebrate Black History Month, we asked our staff from Black, Asian and Minority Ethnic (BAME) communities to share their thoughts on what the month means to them, the centuries-long contribution of BAME communities to healthcare, and how Black history can be recognised and celebrated beyond just one month. Today, we hear from Vibha Teli, principal pharmacy technician for clinical trials. Read more
Clinicians at Royal Brompton and Harefield hospitals have developed a programme to improve the survival of patients with cardiogenic shock – the first comprehensive cardiogenic shock service in the UK. Cardiogenic shock is a life-threatening condition, where the heart is unable to pump a sufficient amount of blood around the body, leading to progressive and rapid failure of all the organs, and is associated with a high risk of death. If it is recognised early enough, appropriate specialist intervention significantly increases the chances of survival. Read more
Royal Brompton and Harefield hospitals have been named as performing “better than most trusts” in the Care Quality Commission’s 2020 Adult Inpatient Survey. The annual survey captures feedback from patients who have stayed in hospital for at least one night. Patients are asked about their experience from pre-admission right through to their discharge. This year, Royal Brompton and Harefield received nearly 800 responses from patients who stayed at one of the hospitals between November 2020; the majority of which were overwhelmingly positive. Read more